PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Arizona State University, Edson College, Phoenix, AZ, USA.\', \'Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD, USA.\', \'Research, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, 5901 East 7th Street, Long Beach, CA, 90822, USA.\', \'Division of Nephrology and Hypertension, Harold Simmons Center for Kidney Disease Research and Epidemiology, School of Medicine, University of California Irvine, Orange, CA, USA.\', \'Greater Los Angeles VA Medical Center, Los Angeles, CA, USA.\', \'UCLA Geffen School of Medicine, Los Angeles, CA, USA.\', \'Research, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, 5901 East 7th Street, Long Beach, CA, 90822, USA. elani.streja@va.gov.\', \'Division of Nephrology and Hypertension, Harold Simmons Center for Kidney Disease Research and Epidemiology, School of Medicine, University of California Irvine, Orange, CA, USA. elani.streja@va.gov.\', \'Research, Tibor Rubin VA Medical Center, VA Long Beach Healthcare System, 5901 East 7th Street, Long Beach, CA, 90822, USA. amrita.ahluwalia@va.gov.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40265-021-01639-2
?:hasPublicationType
?:journal
  • Drugs
is ?:pmid of
?:pmid
?:pmid
  • 34914085
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.547
?:rankingScore_hIndex
  • 150
?:title
  • Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all